Form D · Biotechnology
ELIAS Animal Health, LLC
Olathe, KS · CIK 0001626694
Offering snapshot reported May 10, 2017 · SEC filing
- Reported sold
- $714K Offering amount: $800K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Apr 1, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 10, 2017 | Initial | $714,329 | No comparison | 10 | SEC filing |
| Jul 7, 2016 | Initial | $650,150 | No comparison | 14 | SEC filing |
| Apr 29, 2015 | Amendment | $1,999,982 | $977,244vs Dec 1, 2014 | 42 | SEC filing |
| Dec 1, 2014 | Initial | $1,022,738 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-286417
Source: Form D, filed May 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Burton | Director |
| Larry Maddox | Director |
| Mark Patterson | Director |
| Chuck Stephens | Director |
| Tammie A. Wahaus | Director, Executive |
| Gary Wood | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10900 S. Clay Blair Blvd. Suite 700
Olathe, KS, 66061
Olathe, KS, 66061